Report
Ogeday Gurbuz
EUR 9.65 For Business Accounts Only

Hektas (HEKTS TI) - Volume growth continues: Maintain Buy

Hektas’ 2Q19 net profit was slightly below our estimate. Although EBITDA was in-line with our estimates, higher than expected financial expenses caused the bottom-line miss. Revenue was broadly in-line with our estimates.

The agricultural chemicals segment, which made up c80% of Hektas’ revenue in 2Q19 continued to grow strongly as y-y sales volume accelerated in 2Q19. Meanwhile the fertilizer segment sales volumes grew 231% y-y - benefitting from a low base as it became operational only last year.

We adjust our assumptions to factor the announcement of the newly rented relatively large property and trim our TP. We maintain BUY on the stock as we expect significant revenue and profit growth for the next 4 years given the nearly 55% capacity expansion in agricultural chemicals and a  sevenfold capacity expansion in the fertilizer segment.

Underlying
Hektas Ticaret T.A.S.

Hektas Ticaret TAS. Hektas Ticaret TAS (Hektas) is a Turkey-based company engaged in the production and marketing of agricultural chemicals and veterinary products and medicines. The Company operates two factories in the Gebze and Sanliurfa Organized Industry Zones. The Gebze Plant has an annual production capacity of 52,766 tons, whereas the Sanliurfa Plant has an annual capacity of 22,360 tons. It offers agrochemicals and veterinary products, including agricultural and home insecticides, herbicides, fungicides, foliar fertilizers, plant growth regulators, fumigants, organic farming products, antibacterial and antiparasitic drugs, vitamins and hormones. The Company's products are marketed to over 1,500 dealers and distributors of agricultural chemicals and pesticides through its regional offices in seven cities across Turkey. The Company is a subsidiary of OYAK.

Provider
Teb Yatirim
Teb Yatirim

TEB Investment equity research analysts and strategist team consists of 8 analysts with an average finance sector experience of 15 years and special focus on international investors.

With our 6 equity research analysts we cover 93 companies across 21 sectors, reflecting 80% of the total market capitalization of all BIST companies and 86% of the BIST100 companies. Our strategy team provides in depth top-down and bottom-up market views with insight on FX and bond markets by publishing sectoral and strategic reports both in English and Turkish.

Analysts
Ogeday Gurbuz

Other Reports on these Companies
Other Reports from Teb Yatirim

ResearchPool Subscriptions

Get the most out of your insights

Get in touch